Advertisement
Screener

IRADIMED CORPORATION (IRMD) EBITDA

IRADIMED CORPORATION (IRMD) EBITDA

  • 2026-06-30: Basis Reported; EBITDA $6.80M*; Operating income $6.39M; Depreciation and amortization $410.00K*.
  • 2026-03-31: Basis Reported; EBITDA $7.69M; Operating income (m); Depreciation and amortization (m).
  • 2025-12-31: Basis Reported; EBITDA $7.47M; Operating income (m); Depreciation and amortization (m).
  • 2025-09-30: Basis Reported; EBITDA $7.22M*; Operating income $6.83M; Depreciation and amortization $383.32K*.

Complete source-backed ebitda history.

Available history
2013-12-31 to 2026-03-31
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-06-30Reported$6.80M*$6.39M$410.00K*$20.47M33.23%*$185.00K*$5.94M*(m)$657.00K(m)$1.67M
2026-03-31Reported$7.69M(m)(m)(m)(m)$403.00K$8.29M(m)$956.00K(m)$1.95M
2025-12-31Reported$7.47M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2025-09-30Reported$7.22M*$6.83M$383.32K*$21.20M34.04%*$1.14M*$6.99M*(m)$674.36K(m)$1.72M
2025-06-30Reported$7.00M*$6.79M$208.00K*$20.41M34.28%*$2.64M*$7.75M*(m)$877.00K(m)$1.55M
2025-03-31Reported$5.63M(m)(m)(m)(m)$3.70M$4.29M(m)$624.00K(m)$1.26M
2024-12-31Reported$6M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2024-09-30Reported$5.99M*$5.79M$197.57K*$18.33M32.67%*$3.81M*$9.12M*(m)$639.47K(m)$1.37M
2024-06-30Reported$5.83M*$5.63M$199.13K*$17.93M32.50%*$1.13M*$6.64M*(m)$801.13K(m)$1.37M
2024-03-31Reported$4.97M(m)(m)(m)(m)$270.57K$3.88M(m)$821.00K(m)$1.11M
2023-12-31Reported$5.37M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2023-09-30Reported$6.10M*$5.91M$189.90K*$16.50M36.93%*$308.09K*$1.39M*(m)$452.56K(m)$1.34M
2023-06-30Reported$5.15M*$4.96M$187.36K*$16.13M31.93%*$204.59K*$3.51M*(m)$961.95K(m)$1.12M
2023-03-31Reported$4.19M(m)(m)(m)(m)$6.40M$4.65M(m)$3.00M(m)$943.59K
2022-12-31Reported$3.56M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2022-09-30Reported$4.57M*$4.13M$435.48K*$13.41M34.07%*$192.95K*$3.94M*(m)$491.64K(m)$810.38K
2022-06-30Reported$4.66M*$4.17M$494.18K*$12.72M36.64%*$188.58K*$1.64M*(m)$662.60K(m)$938.63K
2022-03-31Reported$3.51M(m)(m)(m)(m)$183.35K$1.43M(m)$519.10K(m)$573.29K
2021-12-31Reported$3.5M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2021-09-30Reported$3.43M*$3.09M$340.13K*$10.91M31.42%*$150.76K*$3.38M*(m)$480.70K(m)$517.77K
2021-06-30Reported$2.19M*$1.84M$348.30K*$9.81M22.35%*$108.22K*$3.57M*(m)$453.68K(m)$387.73K
2021-03-31Reported$2.11M(m)(m)(m)(m)$132.32K$943.08K(m)$475.82K(m)$384.49K
2020-12-31Reported$990,038.00(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2020-09-30Reported$1.12M*$784.76K$330.99K*$7.70M14.49%*$48.73K*$1.33M*(m)$476.88K(m)-$280.54K
2020-06-30Reported-$2.61M*-$2.93M$324.04K*$6.79M-38.34%*$133.97K*$790.60K*(m)$482.65K(m)-$798.99K
2020-03-31Reported$1.08M(m)(m)(m)(m)$166.59K$1.20M(m)$430.28K(m)-$933.47K
2019-12-31Reported$2.52M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2019-09-30Reported$2.81M*$2.52M$288.92K*$9.96M28.18%*$77.41K*$3.14M*(m)$369.53K(m)$174.03K
2019-06-30Reported$2.66M*$2.38M$285.60K*$9.23M28.85%*$36.02K*$2.48M*(m)$331.31K(m)$364.99K
2019-03-31Reported$1.9M(m)(m)(m)(m)$82.94K$665.20K(m)$352.57K(m)-$239.15K
2018-12-31Reported$2.05M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2018-09-30Reported$1.46M*$1.45M$14.72K*$7.61M19.21%*$45.28K*$727.93K*(m)$373.58K(m)-$909.62K
2018-06-30Reported$2.08M*$1.68M$402.42K*$7.38M28.17%*$67.34K*$1.52M*(m)$395.99K(m)$348.38K
2018-03-31Reported$1.52M(m)(m)(m)(m)$37.98K$1.58M(m)$379.83K(m)$286.20K
2017-12-31Reported$1.34M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2017-09-30Reported$533.95K*$196.06K$337.89K*$5.69M9.38%*$241.97K*$1.91M*(m)$382.70K(m)$32.38K
2017-06-30Reported$673.27K*$327.57K$345.70K*$5.52M12.19%*$170.80K*$291.53K*(m)$449.01K(m)-$8.36K
2017-03-31Reported$48,735.00(m)(m)(m)(m)$240.40K-$184.65K(m)$541.29K(m)$24.48K
2016-12-31Reported$1.75M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2016-09-30Reported$3.18M*$2.59M$587.13K*(m)(m)$123.04K*$3.42M*(m)$457.13K(m)$1.03M
2016-06-30Reported$3.40M*$3.34M$61.83K*(m)(m)$224.71K*(m)(m)$291.82K(m)$1.10M
2016-03-31Reported$3.54M(m)(m)(m)(m)$199.34K(m)(m)$234.34K(m)$1.23M
2015-12-31Reported$4M(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2015-09-30Reported$3.26M*$3.20M$57.45K*(m)(m)$71.95K*(m)(m)$518.56K(m)$1.40M
2015-06-30Reported$2.75M*$2.69M$54.95K*(m)(m)$81.12K*(m)(m)$403.45K(m)$969.28K
2015-03-31Reported$2.32M(m)(m)(m)(m)$40.29K(m)(m)$342.30K(m)$823.83K
2014-12-31Reported$274,796.00(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2014-09-30Reported$451.48K*$406.31K$45.18K*(m)(m)$286.08K*(m)(m)$303.46K(m)$160.14K
2014-06-30Reported$1.64M*$1.61M$33.69K*(m)(m)$214.13K*(m)(m)$225.50K(m)$602.93K
2014-03-31Reported$844,851.00(m)(m)(m)(m)$4.29K(m)(m)$224.30K(m)$304.17K
2013-12-31Reported$763,949.00(m)(m)(m)(m)(m)(m)(m)(m)(m)(m)
2013-09-30Reported$388.60K*$355.84K$32.76K*(m)(m)$82.99K*(m)(m)$299.42K(m)$113.98K
2013-06-30Reported(m)$779.70K(m)(m)(m)(m)(m)(m)$204.42K(m)$244.13K

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2025-12-31Reported$27.31M(m)(m)(m)(m)$7.76M$24.95M(m)$2.98M(m)$5.88M
2024-12-31Reported$22.78M(m)(m)(m)(m)$8.01M$25.62M(m)$2.83M(m)$5.04M
2023-12-31Reported$20.8M(m)(m)(m)(m)$7.44M$13.47M(m)$2.86M(m)$4.55M
2022-12-31Reported$16.3M(m)(m)(m)(m)$823.02K$10.04M(m)$2.28M(m)$3.35M
2021-12-31Reported$11.22M(m)(m)(m)(m)$482.32K$11.26M(m)$1.91M(m)$510.82K
2020-12-31Reported$582,733.00(m)(m)(m)(m)$443.00K$5.82M(m)$1.90M(m)-$1.99M
2019-12-31Reported$9.89M(m)(m)(m)(m)$368.28K$10.23M(m)$1.43M(m)-$587.64K
2018-12-31Reported$7.11M(m)(m)(m)(m)$228.31K$7.38M(m)$1.52M(m)-$106.14K
2017-12-31Reported$2.59M(m)(m)(m)(m)$775.57K$3.42M(m)$1.72M(m)$896.62K
2016-12-31Reported$11.88M(m)(m)(m)(m)$780.81K$9.41M(m)$1.35M(m)$3.74M
2015-12-31Reported$12.32M(m)(m)(m)(m)$298.72K$7.65M(m)$1.76M(m)$4.10M
2014-12-31Reported$3.21M(m)(m)(m)(m)$583.98K(m)(m)$1.07M(m)$966.98K
2013-12-31Reported$2.93M(m)(m)(m)(m)$163.18K(m)(m)$1.01M(m)$846.88K

Similar stocks

Stock NameCountryMarket CapPE Ratio
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57
ARTIVION, INC. (AORT)United States$1.123B-345.09
PROCEPT BioRobotics Corp (PRCT)United States$1.001B-11.77
Beta Bionics, Inc. (BBNX)United States$0.979B-9.66
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
SpyGlass Pharma, Inc. (SGP)United States$0.925B
SI-BONE, Inc. (SIBN)United States$0.830B-49.82
MIMEDX GROUP, INC. (MDXG)United States$0.687B89.92
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02